Akèy › Twoub bipolè
Etid klinik pou Twoub bipolè ap rekrite nan Etazini
59 etid pou Twoub bipolè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX10 etid
- Boston, MA7 etid
- New York City, NY7 etid
- Little Rock, AR6 etid
- Atlanta, GA6 etid
- Austin, TX5 etid
- Miami, FL5 etid
- Orange, CA5 etid
- Hialeah, FL5 etid
- Cambridge, MA5 etid
- Chicago, IL4 etid
- West Palm Beach, FL4 etid
- Philadelphia, PA4 etid
- Rochester, MN4 etid
- Anaheim, CA4 etid
- Bellevue, WA4 etid
- O'Fallon, MO4 etid
- Cincinnati, OH4 etid
- Everett, WA4 etid
- Orlando, FL4 etid
- San Diego, CA4 etid
- Staten Island, NY3 etid
- Richardson, TX3 etid
- Savannah, GA3 etid
- Washington, DC3 etid
- Sugar Land, TX3 etid
- Parma, OH3 etid
- San Bernardino, CA3 etid
- Oklahoma City, OK3 etid
- Naperville, IL3 etid
- Gainesville, FL3 etid
- Richmond, VA3 etid
Pa eta
- Arizona3 etid
- Arkansas6 etid
- Connecticut3 etid
- Florid8 etid
- Georgia9 etid
- Illinois7 etid
- Iowa3 etid
- Kalifòni17 etid
- Maryland5 etid
- Massachusetts10 etid
- Michigan4 etid
- Minnesota6 etid
- Missouri5 etid
- Nebraska3 etid
- New York10 etid
- Ohio6 etid
- Oklahoma5 etid
- Pennsylvania7 etid
- Texas16 etid
- Virginia4 etid
- Washington5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 3 a 99 · Tout sèks · Mizajou Sep 28, 2026 · NCT00024635Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Ap rekriteFaz 3
Laj 5 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT06229210Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT06372964Neuromodulation of Mood Switch Circuitry in Bipolar Disorder
Ap rekriteFaz 4
Laj 18 a 70 · Tout sèks · Mizajou Sep 23, 2026 · NCT07680153A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07286175Safety and Feasibility of DBS for Bipolar Depression
Ap rekrite
Laj 22 a 70 · Tout sèks · Mizajou Sep 22, 2026 · NCT07745374A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07105111A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Adult Participants With Bipolar Disorder
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 16, 2026 · NCT07071532The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07699445A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Sep 2, 2026 · NCT07172516Enhancing Veteran-Clinical Collaboration in VA PRRCs
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT06898879Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
Ap rekrite
Laj 18 a 45 · Tout sèks · Mizajou Aug 17, 2026 · NCT06221852Ketogenic Intervention for Bipolar Depression
Ap rekrite
Laj 18 a 50 · Tout sèks · Mizajou Aug 17, 2026 · NCT07121894A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Aug 14, 2026 · NCT06696755Natural History of Depression, Bipolar Disorder and Suicide Risk
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Aug 14, 2026 · NCT06462196NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 8 a 70 · Tout sèks · Mizajou Aug 13, 2026 · NCT05669703Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy
Ap rekriteFaz 2/3
Laj 18 a 90 · Tout sèks · Mizajou Aug 12, 2026 · NCT06529029Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
Ap rekriteFaz 2
Laj 25 a 70 · Tout sèks · Mizajou Aug 12, 2026 · NCT06706232Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Ap rekriteFaz 1
Laj 10 a 17 · Tout sèks · Mizajou Aug 11, 2026 · NCT05025605Healthy Lifestyles for Bipolar Disorder
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Aug 4, 2026 · NCT06188754Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder
Ap rekrite
Laj 24 a 65 · Tout sèks · Mizajou Jul 16, 2026 · NCT06274567Exercise and Olanzapine-samidorphan
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Jul 13, 2026 · NCT06740890A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT05537376A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jun 23, 2026 · NCT07140913RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Jun 22, 2026 · NCT07266545Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.